中国首个国产原创Bcl-2抑制剂利沙托克拉纳入新版国家医保目录,亚盛医药(06855)双引擎布局与全球开发同步推进
Last Update:
14 11 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.